| Gene symbol | CD79B | Synonyms | AGM6, B29, IGB, Igbeta | Type of gene | protein-coding | |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | Entrez:974 MIM:147245 HGNC:HGNC:1699 Ensembl:ENSG00000007312 AllianceGenome:HGNC:1699 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | CD79b molecule | |||||
| GTO ID | GTC0823 |
| Trial ID | ChiCTR1900025891 |
| Disease | B-Cell Malignancy |
| Altered gene | CD79b |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD79b CAR-T cells |
| Recruitment status | Recruiting |
| Title | Clinical study for anti-CD79b CAR-T in the treatment of refractory or recurrent CD79b+ B cell malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||